A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia

[1]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  M. Kurtz,et al.  Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. , 2012, Schizophrenia bulletin.

[3]  D. Velligan,et al.  Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia , 2012, Schizophrenia Research.

[4]  B. Gajewski,et al.  Patterns of association between performance in a natural environment and measures of executive function in people with schizophrenia , 2011, Psychiatry Research.

[5]  M. Keshavan,et al.  Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  K. Goto,et al.  Hormonal Responses to Resistance Exercise after Ingestion of Carnosine and Anserine , 2011, Journal of strength and conditioning research.

[7]  D. Matsuzawa,et al.  Enhanced carbonyl stress in a subpopulation of schizophrenia. , 2010, Archives of general psychiatry.

[8]  A. Markou,et al.  The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice , 2010, Psychopharmacology.

[9]  P. He,et al.  Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. , 2010, Free radical biology & medicine.

[10]  M. Egan,et al.  Set-Shifting Ability and Schizophrenia: A Marker of Clinical Illness or an Intermediate Phenotype? , 2008, Biological Psychiatry.

[11]  M. Farooq,et al.  Differential neuroprotective effects of carnosine, anserine, and N‐acetyl carnosine against permanent focal ischemia , 2008, Journal of neuroscience research.

[12]  M. Cuénod,et al.  N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial , 2008, Biological Psychiatry.

[13]  Reto Meuli,et al.  Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients , 2008, Neuropsychopharmacology.

[14]  Philip D. Harvey,et al.  Predicting Schizophrenia Patients’ Real-World Behavior with Specific Neuropsychological and Functional Capacity Measures , 2008, Biological Psychiatry.

[15]  Michael F. Green,et al.  Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. , 2008, The American journal of psychiatry.

[16]  Michael F. Green,et al.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. , 2008, The American journal of psychiatry.

[17]  R. Keefe.  Cognitive deficits in patients with schizophrenia: effects and treatment. , 2007, The Journal of clinical psychiatry.

[18]  Philip D. Harvey,et al.  Self-assessment of functional status in schizophrenia. , 2007, Journal of psychiatric research.

[19]  A. Majid,et al.  Carnosine Is Neuroprotective Against Permanent Focal Cerebral Ischemia in Mice , 2007, Stroke.

[20]  D. Javitt,et al.  The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. , 2007, The American journal of psychiatry.

[21]  E. Wei,et al.  Carnosine protects against NMDA-induced neurotoxicity in differentiated rat PC12 cells through carnosine-histidine-histamine pathway and H(1)/H(3) receptors. , 2007, Biochemical pharmacology.

[22]  R. Keep,et al.  PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes , 2006, Brain Research.

[23]  M. Ding,et al.  Effects of carnosine on amygdaloid-kindled seizures in Sprague–Dawley rats , 2005, Neuroscience.

[24]  D. Dobrota,et al.  Carnosine Protects the Brain of Rats and Mongolian Gerbils against Ischemic Injury: After-Stroke-Effect , 2005, Neurochemical Research.

[25]  R. Bilder,et al.  P.6.069 Standardisation and cross validation study ofCogtest — an automated neurocognitive battery for use in clinical trials , 2004, European Neuropsychopharmacology.

[26]  Bita Moghaddam,et al.  Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. , 2003, Behavioral neuroscience.

[27]  S. McGurk,et al.  Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. , 2003, Psychiatric services.

[28]  M. Chez,et al.  Double-Blind, Placebo-Controlled Study of L-Carnosine Supplementation in Children With Autistic Spectrum Disorders , 2002, Journal of child neurology.

[29]  Philip D. Harvey,et al.  Cognition in schizophrenia , 2001, Current psychiatry reports.

[30]  R. Keep,et al.  PEPT2-Mediated Uptake of Neuropeptides in Rat Choroid Plexus , 2001, Pharmaceutical Research.

[31]  C. Chow,et al.  High levels of dietary carnosine are associated with increased concentrations of carnosine and histidine in rat soleus muscle. , 2001, The Journal of nutrition.

[32]  A. Belger,et al.  Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions , 2000, Biological Psychiatry.

[33]  T. Robbins,et al.  Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage , 1999, Schizophrenia Research.

[34]  J. Smythies.  Redox mechanisms at the glutamate synapse and their significance: a review. , 1999, European journal of pharmacology.

[35]  J. Hinnie,et al.  Textbook of biochemistry with clinical correlations , 1999 .

[36]  A. Hipkiss,et al.  Pluripotent Protective Effects of Carnosine, a Naturally Occurring Dipeptidea , 1998, Annals of the New York Academy of Sciences.

[37]  A. Bakardjiev.  Carnosine and β‐alanine release is stimulated by glutamatergic receptors in cultured rat oligodendrocytes , 1998 .

[38]  S. Mukherjee,et al.  Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis , 1998, Biological Psychiatry.

[39]  T. Robbins,et al.  Executive function in first-episode schizophrenia , 1998, Psychological Medicine.

[40]  T. Robbins,et al.  Executive function in first episode schizophrenia: Improvement at one year , 1998, Schizophrenia Research.

[41]  A. Hipkiss,et al.  Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells , 1997, Neuroscience Letters.

[42]  M. Sassoè-Pognetto,et al.  Co-localization of carnosine and glutamate in photoreceptors and bipolar cells of the frog retina , 1997, Brain Research.

[43]  D. Carpenter,et al.  Biochemical and Physiological Evidence that Carnosine Is an Endogenous Neuroprotector Against Free Radicals , 1997, Cellular and Molecular Neurobiology.

[44]  M. Jackson,et al.  The distribution of carnosine and related dipeptides in rat and human tissues , 1996, Inflammation Research.

[45]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[46]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[47]  M. Giustetto,et al.  Presynaptic colocalization of carnosine and glutamate in olfactory neurones , 1993, Neuroreport.

[48]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[49]  M L Gardner,et al.  Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose. , 1991, The Journal of physiology.

[50]  Jean Addington,et al.  A depression rating scale for schizophrenics , 1990, Schizophrenia Research.

[51]  T. Goldberg,et al.  Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. , 1987, Archives of general psychiatry.

[52]  T. Hama,et al.  The utilization of carnosine in rats fed on a histidine-free diet and its effect on the levels of tissue histidine and carnosine. , 1984, Journal of nutritional science and vitaminology.

[53]  P. W. Chan,et al.  Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[54]  P. Johnson,et al.  Purification of carnosine synthetase from avian muscle by affinity chromatography and determination of its subunit structure. , 1981, Biochimica et biophysica acta.

[55]  F. Margolis,et al.  Denervation in the primary olfactory pathway of mice. III. Effect on enzymes of carnosine metabolism , 1976, Brain Research.

[56]  Jacob Cohen.  Measurement Educational and Psychological Educational and Psychological Measurement Eta-squared and Partial Eta-squared in Fixed Factor Anova Designs Educational and Psychological Measurement Additional Services and Information For , 2022 .

[57]  E. Kraepelin.  Die erscheinungsformen des Irreseins , 1920 .

[58]  D. Javitt.  Glutamate involvement in schizophrenia : Focus on N-methyl-D-aspartate receptors , 2006 .

[59]  Jeffrey K. Yao,et al.  Oxidative Damage and Schizophrenia , 2001, CNS drugs.

[60]  T L Patterson,et al.  UCSD Performance-Based Skills Assessment , 2016 .

[61]  Philip D. Harvey,et al.  Cognition in schizophrenia : impairments, importance, and treatment strategies , 2000 .

[62]  A. Torreggiani,et al.  Hydroxyl radical scavenging by carnosine and Cu(II)-carnosine complexes: a pulse-radiolysis and spectroscopic study. , 1999, International journal of radiation biology.

[63]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[64]  P. Quinn,et al.  Carnosine: its properties, functions and potential therapeutic applications. , 1992, Molecular aspects of medicine.

[65]  L. Mørkrid,et al.  Inborn errors of carnosine and homocarnosine metabolism. , 1990, Journal of neural transmission. Supplementum.

[66]  A. Lehman,et al.  A Quality of Life Interview for the chronically mentally ill. , 1988 .

[67]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[68]  T. M. Devlin,et al.  Textbook of biochemistry: With clinical correlations , 1982 .